Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexaria Corp (LXRP)

Lexaria Corp (LXRP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.43
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2622 +5.87%
on 07/01/20
0.3310 -16.13%
on 07/01/20
-0.0124 (-4.28%)
since 06/05/20
3-Month
0.2179 +27.40%
on 05/14/20
0.4022 -30.98%
on 05/27/20
-0.0140 (-4.80%)
since 04/07/20
52-Week
0.2179 +27.40%
on 05/14/20
1.0000 -72.24%
on 08/12/19
-0.5826 (-67.73%)
since 07/05/19

Most Recent Stories

More News
Lexaria Bioscience Engages Investor Relations and Capital Markets Advisory Firm for its Shareholder Communications Program

KELOWNA, BC / ACCESSWIRE / June 29, 2020 / Lexaria Bioscience Corp. (OTCQX:)(CSE:) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announced it has retained IRTH Communications,...

LXX.CN : 0.370 (-3.90%)
LXRP : 0.2776 (-4.21%)
Lexaria Bioscience Engages Investor Relations and Capital Markets Advisory Firm for its Shareholder Communications Program

(via TheNewswire)

LXRP : 0.2776 (-4.21%)
LXX.CN : 0.370 (-3.90%)
Lexaria Announces 2020 Annual and Special Meeting Results

(via TheNewswire)

LXRP : 0.2776 (-4.21%)
LXX.CN : 0.370 (-3.90%)
Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License

(via TheNewswire)

LXRP : 0.2776 (-4.21%)
LXX.CN : 0.370 (-3.90%)
Medical Marijuana Market To Grow During 2020-28 On Account Of Increasing Adult Patients With Chronic Diseases

Research Nester published a report titled which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.

ACB.TO : 16.84 (+2.43%)
LXX.CN : 0.370 (-3.90%)
TLRY : 7.70 (-1.91%)
WEED.TO : 22.42 (-2.31%)
APHA : 4.33 (-1.14%)
GWPH : 129.62 (+2.44%)
ACB : 12.42 (+1.97%)
MRRCF : 0.0043 (-4.44%)
LXRP : 0.2776 (-4.21%)
CNABQ : 0.0200 (unch)
Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services

KELOWNA, BC / ACCESSWIRE / June 1, 2020 / Lexaria Bioscience Corp. (OTCQX:)(CSE:) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has retained PCG Advisory, Inc....

LXX.CN : 0.370 (-3.90%)
LXRP : 0.2776 (-4.21%)
Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services

(via TheNewswire)

LXRP : 0.2776 (-4.21%)
LXX.CN : 0.370 (-3.90%)
Lexaria Bioscience Confirms Closing of US$2,039,228 Private Placement

(via TheNewswire)

LXRP : 0.2776 (-4.21%)
LXX.CN : 0.370 (-3.90%)
Lexaria Bioscience Announces Over US$2,000,000 Private Placement

KELOWNA, BC / ACCESSWIRE / May 4, 2020 / Lexaria Bioscience Corp. (OTCQB:)(CSE:) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into definitive...

LXX.CN : 0.370 (-3.90%)
LXRP : 0.2776 (-4.21%)
Lexaria Receives Notice of Allowance for New Patent and Awards Stock Options

(via TheNewswire)

LXRP : 0.2776 (-4.21%)
LXX.CN : 0.370 (-3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade LXRP with:

Key Turning Points

2nd Resistance Point 0.2923
1st Resistance Point 0.2849
Last Price 0.2776
1st Support Level 0.2703
2nd Support Level 0.2631

See More

52-Week High 1.0000
Fibonacci 61.8% 0.7012
Fibonacci 50% 0.6090
Fibonacci 38.2% 0.5167
Last Price 0.2776
52-Week Low 0.2179

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar